Avalo Therapeutics AVTX
NASDAQ AVTX
$14.99 +0.04 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Price to FCF (2017 - 2018)

Updated

Avalo Therapeutics' (AVTX) Price to FCF was 9.22 for Q2 2018, down 0.9% from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Price to FCF (2017 - 2018) Analysis & Trends

For FY2017, Price to FCF at Avalo Therapeutics was 11.87.

  • Five-year quarterly Price to FCF spans a low of 4.26 in Q3 2017 and a high of 11.87 in Q4 2017.
  • Per Business Quant data, the three quarters before Q2 2018 came in at 9.30 (Q1 2018), 11.87 (Q4 2017) and 4.26 (Q3 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Avalo Therapeutics 653.59 Mn 653.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 9.22
Mar 31, 2018 9.30
Dec 31, 2017 11.87
Sep 30, 2017 4.26
API Access

Avalo Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=AVTX&period=max&api_key=YOUR_API_KEY